These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21801476)

  • 21. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea.
    Park Y; Lee A; Shim SC; Lee JH; Choe JY; Ahn H; Choi CB; Sung YK; Bae SC
    J Nutr Biochem; 2013 Jul; 24(7):1367-72. PubMed ID: 23333088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: a randomized, double-blind placebo-controlled study.
    Gholamhosseini S; Nematipour E; Djazayery A; Javanbakht MH; Koohdani F; Zareei M; Djalali M
    Nutrition; 2015 Mar; 31(3):480-4. PubMed ID: 25701338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.
    Siener R; Alteheld B; Terjung B; Junghans B; Bitterlich N; Stehle P; Metzner C
    Eur J Clin Nutr; 2010 Apr; 64(4):410-8. PubMed ID: 20160750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
    Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.
    O'Doherty MG; Gilchrist SE; Young IS; McKinley MC; Yarnell JW; Gey KF; Evans A; Skidmore PM; Woodside JV
    Eur J Nutr; 2010 Dec; 49(8):483-92. PubMed ID: 20401662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutrient supplementation with polyunsaturated fatty acids and micronutrients in rheumatoid arthritis: clinical and biochemical effects.
    Remans PH; Sont JK; Wagenaar LW; Wouters-Wesseling W; Zuijderduin WM; Jongma A; Breedveld FC; Van Laar JM
    Eur J Clin Nutr; 2004 Jun; 58(6):839-45. PubMed ID: 15164103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-chain n-3 PUFA supplementation decreases physical activity during class time in iron-deficient South African school children.
    Smuts CM; Greeff J; Kvalsvig J; Zimmermann MB; Baumgartner J
    Br J Nutr; 2015 Jan; 113(2):212-24. PubMed ID: 25471216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
    Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
    Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
    Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
    Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term homocysteine reduction with B vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography: a randomised double-blind, placebo-controlled trial.
    Potter K; Lenzo N; Eikelboom JW; Arnolda LF; Beer C; Hankey GJ
    Cerebrovasc Dis; 2009; 27(3):259-65. PubMed ID: 19202330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supplementation with a low-moderate dose of n-3 long-chain PUFA has no short-term effect on bone resorption in human adults.
    Appleton KM; Fraser WD; Rogers PJ; Ness AR; Tobias JH
    Br J Nutr; 2011 Apr; 105(8):1145-9. PubMed ID: 21129235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
    Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
    JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment.
    Oulhaj A; Jernerén F; Refsum H; Smith AD; de Jager CA
    J Alzheimers Dis; 2016; 50(2):547-57. PubMed ID: 26757190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The content of docosahexaenoic acid in serum phospholipid is inversely correlated with plasma homocysteine levels in patients with end-stage renal disease.
    Rasmussen LE; Svensson M; Jørgensen KA; Schmidt EB; Christensen JH
    Nutr Res; 2010 Aug; 30(8):535-40. PubMed ID: 20851307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial.
    Andreeva VA; Kesse-Guyot E; Barberger-Gateau P; Fezeu L; Hercberg S; Galan P
    Am J Clin Nutr; 2011 Jul; 94(1):278-86. PubMed ID: 21593490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive performance in relation to vitamin status in healthy elderly German women-the effect of 6-month multivitamin supplementation.
    Wolters M; Hickstein M; Flintermann A; Tewes U; Hahn A
    Prev Med; 2005 Jul; 41(1):253-9. PubMed ID: 15917019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do B Vitamins Enhance the Effect of
    Zhu J; Xun PC; Kolencik M; Yang KF; Fly AD; Kahe K
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SU.FOL.OM3 Study: a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics.
    Galan P; Briancon S; Blacher J; Czernichow S; Hercberg S
    Trials; 2008 Jun; 9():35. PubMed ID: 18544171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation.
    Kemperman RF; Veurink M; van der Wal T; Knegtering H; Bruggeman R; Fokkema MR; Kema IP; Korf J; Muskiet FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):75-85. PubMed ID: 16384692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.